USP 795/800 Nonsterile Compounding Compliance & the Role of the Designated Person

Free Webinar Series

September 24 | October 29 | November 19

Are you struggling with USP 795/USP 800 nonsterile compounding compliance in your pharmacy? Having trouble finding the right person to take on the role of “designated person” to ensure knowledge and confidence in this critical area?

Our FREE 3-Part Webinar Series is designed specifically for health care professionals looking to enhance their understanding of and improve compliance in nonsterile compounding.

  • Gain Expertise: Learn from industry experts who will provide actionable insights and valuable guidance.
  • Improve Compliance: Understand the key components of nonsterile compounding compliance to ensure your pharmacy meets all necessary standards.
  • Enhance Quality: Develop competencies and practices that ensure high-quality nonsterile compounding processes.

What You'll Learn

  • Analyze the role of the designated person(s) for nonsterile compounding in health systems.
  • Identify the components of a gap analysis to determine compliance.
  • Assess the role of master formulation records and utilizing them to drive your compliance journey.

Speakers

 

Sebastian Denison, RPh, PCCA Clinical Compounding Pharmacist

 

Trey Tietz, PharmD, MHA, Cleveland Clinic Ambulatory Pharmacy Manager

Tuesday, October 29, 2024
2-3 PM CT

What You'll Learn

  • Distinguish appropriate training for each role associated with nonsterile compounding.
  • Formulate nonsterile compounding competencies.
  • Practice quality assurance and quality control in nonsterile compounding.

Speakers

 

Celeste Zizzamia, PharmD, BCSCP, PCCA Clinical Compounding Pharmacist

 

David Melton, PharmD, BCSCP, Compounding Compliance Pharmacist Specialist and Adjunct Clinical Instructor

Tuesday, November 19, 2024
2-3 PM CT

What You'll Learn

  • Identify types of contamination that can occur within nonsterile compounds and their potential impact on patients.
  • Design appropriate locations for nonsterile compounding to reduce contamination risks.
  • Contrast properties of cleaning and sanitizing agents.

Speakers

 

Matt Lester, RPh, MBA, PCCA Clinical Compounding Pharmacist

 

Stefani Gautreaux, PharmD, MBA MD Anderson Manager, Inpatient Pharmacy Director, Health System Pharmacy Administration Residency